Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Equityinc Regulatory News (AEI)

Share Price Information for Abrdn Equityinc (AEI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 303.00
Bid: 302.00
Ask: 303.00
Change: -5.00 (-1.62%)
Spread: 1.00 (0.331%)
Open: 308.00
High: 308.00
Low: 302.00
Prev. Close: 308.00
AEI Live PriceLast checked at -
abrdn Equity Income is an Investment Trust

To provide shareholders with an above average income from their equity investment while also providing real growth in capital and income by investing in a diversified portfolio consisting mainly of quoted UK equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Feb 2024 14:15

RNS Number : 8077D
abrdn Equity Income Trust plc
20 February 2024
 

ABRDN EQUITY INCOME TRUST PLC

Legal Entity Identifier (LEI): 21380015XPT7BZISSQ74

 

20 February 2024

 

Result of Annual General Meeting

 

At the Annual General Meeting of abrdn Equity Income Trust plc (the "Company") held on Tuesday, 20 February 2024, all the Resolutions as set out in full in the Notice of Meeting included within the Company's Annual Report for the year ended 30 September 2023, available on the Company's website www.abrdnequityincometrust.com*, were duly passed on a show of hands.

 

As set out in the Company's Annual Report to 30 September 2023, Mr Tigue retired from the Board immediately after the Annual General Meeting. 

 

Ms Patel said "The Board wishes to formally thank Mr Tigue for his service to the Board as a Director since 2014, and as Senior Independent Director since 2016." 

 

Ms Hitch will take on the role of Senior Independent Director with immediate effect and Mr Timberlake will take on the role of Chair of the Remuneration & Management Engagement Committee with immediate effect. 

 

The total number of proxy votes lodged was as follows:

 

 

For and Discretionary

Against

Votes

Total Votes

Resolution

No. of

% of

No. of

% of

Withheld

(excluding Votes Withheld)

Number

Votes

Votes Cast

Votes

Votes Cast

 

1. Approve Directors' Report and Financial Statements

5,810,213

99.8

11,793

0.2

44,180

5,822,006

2. Approve Directors' Remuneration Report

5,539,683

95.7

246,332

4.3

80,171

5,786,015

3. Approve Dividend Policy

5,791,836

99.5

26,863

0.5

47,487

5,818,699

4. Re-elect Ms C.M. Hitch 

5,646,905

97.8

126,366

2.2

92,915

5,773,271

5. Re-elect Mr M. Little

5,638,215

98.2

103,477

1.8

124,494

5,741,692

6. Re-elect Ms S. Patel

5,644,964

97.8

128,368

2.2

92,854

5,773,332

7. Elect Mr N. Timberlake

5,661,828

98.6

79,152

1.4

125,206

5,740,980

8. Appoint Johnston Carmichael LLP as Auditor

5,700,418

99.4

35,986

0.6

129,782

5,736,404

9. Remuneration of the Auditor

5,700,540

99.0

57,879

1.0

107,767

5,758,419

10. Allotment of shares

5,724,742

98.0

114,447

2.0

26,997

5,839,189

11. Disapply pre-emption rights

5,607,929

96.6

200,165

3.4

58,092

5,808,094

12. Authorise market purchases of ordinary shares

5,771,791

98.9

65,258

1.1

29,137

5,837,049

13. Notice of General Meetings

5,653,778

97.7

132,929

2.3

79,479

5,786,707

 

Copies of the resolutions passed under special business will shortly be submitted to the National Storage Mechanism and will be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism*.

 

*Neither the NSM website nor the Company's website nor the content of any website accessible from hyperlinks on those websites (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQKKBDQBKDNBB
Date   Source Headline
13th Jun 20244:28 pmRNSPortfolio disclosure
13th Jun 202412:57 pmRNSNet Asset Value(s)
13th Jun 202410:34 amRNSHalf Yearly Report
12th Jun 202411:52 amRNSNet Asset Value(s)
11th Jun 202412:39 pmRNSNet Asset Value(s)
10th Jun 20242:36 pmRNSGearing Disclosure
10th Jun 202412:55 pmRNSNet Asset Value(s)
7th Jun 202412:50 pmRNSNet Asset Value(s)
6th Jun 202412:22 pmRNSNet Asset Value(s)
6th Jun 202411:16 amRNSMonth End Net Asset Value(s)
5th Jun 20241:13 pmRNSNet Asset Value(s)
4th Jun 202411:55 amRNSNet Asset Value(s)
3rd Jun 20242:04 pmRNSGearing Disclosures
31st May 202412:05 pmRNSNet Asset Value(s)
30th May 202411:41 amRNSNet Asset Value(s)
29th May 202411:40 amRNSNet Asset Value(s)
28th May 20242:51 pmRNSGearing disclosure
28th May 202411:42 amRNSNet Asset Value(s)
24th May 20241:10 pmRNSNet Asset Value(s)
23rd May 202412:27 pmRNSNet Asset Value(s)
22nd May 202412:37 pmRNSNet Asset Value(s)
21st May 202412:15 pmRNSNet Asset Value(s)
20th May 20241:03 pmRNSGearing disclosure
20th May 202412:14 pmRNSNet Asset Value(s)
17th May 202412:27 pmRNSNet Asset Value(s)
16th May 20246:06 pmRNSPortfolio disclosure
16th May 202412:21 pmRNSNet Asset Value(s)
15th May 202412:34 pmRNSNet Asset Value(s)
14th May 202411:49 amRNSNet Asset Value(s)
14th May 20247:00 amRNSHalf-year Report
13th May 20242:37 pmRNSGearing disclosure
13th May 202412:23 pmRNSNet Asset Value(s)
10th May 202412:35 pmRNSNet Asset Value(s)
9th May 202412:15 pmRNSNet Asset Value(s)
8th May 202412:54 pmRNSNet Asset Value(s)
7th May 20245:27 pmRNSMonth End Net Asset Value(s)
7th May 202412:49 pmRNSGearing disclosure
7th May 202412:26 pmRNSNet Asset Value(s)
3rd May 202412:54 pmRNSNet Asset Value(s)
2nd May 202412:59 pmRNSNet Asset Value(s)
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:20 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.